Gonadorelin Powder is a highly purified freeze-dried powder formulation. Its active ingredient is the artificially synthesized gonadotropin-releasing hormone (GnRH), which is exactly the same as the natural hormone secreted by the human hypothalamus. This sterile powder is usually packaged in a sterile vial and must be reconstituted with a specific solvent (such as normal saline or sterile water for injection containing benzyl alcohol) before use, dissolved into an injection solution before it can be used.
|
|
|
Gonadorelin COA
Its core pharmacological effect is to precisely simulate the physiological pulses of the human body, stimulating the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby regulating gonadal function and promoting the synthesis of sex hormones and the maturation of gametes. The advantage of the powder form is its extremely high chemical stability, which makes it convenient for long-term storage and transportation under low-temperature and light-proof conditions, thus extending the product's validity period.
It is mainly used in clinical diagnostic fields and is a key tool for evaluating the function of the hypothalamus-pituitary-gonadal axis, used to identify the origin of hypogonadism. In addition, it is also widely used in scientific research and veterinary medicine. It is worth noting that its biological effect highly depends on the precise pulsatile administration mode. Any improper reconstitution (such as using an inappropriate solvent containing preservatives) or continuous administration may render it ineffective or even have inhibitory effects. Therefore, strict aseptic operations and individualized administration must be carried out under the guidance of professional medical personnel.
Gonadorelin powder is a synthetic peptide hormone, also known as GnRH (Gonadotropin-releasing hormone) or LHRH (Luteinizing hormone-releasing hormone). It has various uses in medicine and research.
1. Treatment of reproductive system diseases
Gonadorelin acetate is widely used to treat disorders related to the reproductive system, including male and female infertility, pituitary hypogonadism and other disorders related to the production and release of gonadal hormones. It stimulates the anterior pituitary gland to secrete gonadotropins (LH and FSH), thereby promoting normal function of the ovaries and testes.
2. Fertility treatment
In assisted reproductive technology, Gonadorelin acetate is often used as a therapeutic drug to promote ovarian ovulation. By simulating the natural GnRH release in the body, it can adjust the balance of androgen and estrogen, promote the normal periodic ovulation of the ovary, and increase the chance of pregnancy.
3. Improves stamina and enhances muscle growth
Gonadorelin acetate is used in some fitness and strength training areas as a supplement to increase muscle mass and improve stamina. By specifically stimulating gonadotropin secretion in the anterior pituitary gland, it effectively increases the production of testosterone and estrogen in the body. These hormones play key roles in promoting muscle growth and accelerating muscle repair after intense training, helping to reduce muscle soreness and shorten recovery time. It also helps improve exercise endurance, allowing athletes and fitness enthusiasts to maintain higher intensity training for a longer period, thereby achieving better training results.
4. Cancer treatment research
Gonadorelin acetate also has applications in cancer treatment research. Due to its ability to regulate the secretion of gonadal hormones in the body, it has been widely used in preclinical and clinical studies to explore its effect on hormone-dependent tumors that grow with the support of gonadal hormones. Additionally, it is clinically applied to treat certain types of breast and prostate cancer-by suppressing the levels of estrogen or testosterone that promote tumor growth, it can inhibit tumor progression and improve the prognosis of patients, often used in combination with other anti-tumor drugs to enhance therapeutic efficacy.
5. Animal Research and Breeding Control
Gonadorelin acetate also has applications in animal research and animal husbandry. It is used to regulate the reproductive cycle of animals and control reproduction. Gonadorelin acetate can be used to promote or inhibit gonadal hormone secretion and ovarian or testicular function in animals, as required.
These are some of the main uses of Gonadorelin acetate. Its diverse applications in medicine and research make it an important pharmaceutical and research tool. However, when using Gonadorelin acetate, you must follow the guidance of a doctor or professional, and the dosage and course of treatment need to be determined according to the specific situation.
Synthesis Method
The first step in the synthesis of Gonadorelin acetate is to synthesize the polypeptide chain. Polypeptide chains are made up of a series of amino acids linked together in a specific order. This synthesis usually adopts solid-phase synthesis method or liquid-phase synthesis method. In solid-phase synthesis, the starting amino acid is attached to the solid-phase material through a protecting group, and amino acids are added through cycles of reaction and protecting group removal until the complete polypeptide chain is synthesized.
After the synthesis of the polypeptide chain is completed, the acyl group (acetate) needs to be connected to the hydroxyl group of the polypeptide to form Gonadorelin acetate. This step usually uses an activator (such as dimethyl sulfoxide, dimethyl carboimide, etc.) and carbonic anhydride for acylation. The acyl group reacts with the hydroxyl group on the polypeptide chain to form an ester bond, which fixes the acyl group in the polypeptide.
The final step in the synthesis of Gonadorelin acetate is to obtain the final product through a bond cleavage reaction. This step usually uses acidic or basic conditions to cleave specific bonds and release Gonadorelin acetate. The conditions and methods for bond cleavage depend on the requirements of specific synthetic schemes.
In addition to the basic steps above, there are some common methods used to synthesize Gonadorelin acetate, including:
1. Boc strategy:
The Boc (t-Butyloxycarbonyl) protecting group strategy is a commonly used protecting group strategy for peptide synthesis. In the synthesis of Gonadorelin acetate, the Boc strategy can be used to protect the amino groups of amino acids. Through cycles of selective deprotection and protection, complete polypeptide chains can be synthesized stepwise.
2. Fmoc strategy:
The Fmoc (Fluorenylmethoxycarbonyl) protecting group strategy is another widely used protecting group strategy for peptide synthesis. Unlike the Boc strategy, the Fmoc strategy uses the Fmoc group to protect the amino groups of amino acids. Through cycles of reaction and deprotection, complete polypeptide chains can be synthesized step-by-step.
These are brief descriptions of the basic steps and common methods for the synthesis of the product. Actual synthetic protocols may vary depending on research objectives, reaction conditions, and personal preference of the chemist. Note that the synthesis of it is a complex process that needs to be carried out under suitable laboratory conditions and performed by an experienced chemist or researcher.
Gonadorelin powder is a synthetic hormone that belongs to the gonadotropin-releasing hormone (GnRH) family. The molecular structure characteristics of Gonadorelin acetate mainly include the following aspects:
Polypeptide chain structure:
Gonadorelin acetate is a polypeptide chain composed of 10 amino acids, also known as decapeptide in biology. These amino acids are linked together in a specific order to form the molecular structure of Gonadorelin acetate.
Amino acid sequence:
The amino acid sequence of Gonadorelin acetate is pyroGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2. Among them, pyroGlu represents the "pyroglutamic acid" residue at the N-terminus, and NH2 represents the terminal group at the C-terminus. The specific arrangement of the amino acid sequence determines the biological activity and pharmacological effects of Gonadorelin acetate.
Peptidic Bonds:
Each amino acid in Gonadorelin Acetate is linked together by peptide bonds to form a polypeptide chain. Peptide bonds are covalent bonds of carbon and nitrogen compounds between amino acids and have specific structural and chemical properties. These peptide bonds connect the carboxyl and amino groups of the amino acids, forming the backbone of the Gonadorelin acetate molecule.
Acetate group:
Gonadorelin acetate contains an acetate group (CH3COO-) in its chemical structure. The acetic acid group usually undergoes an esterification reaction with the hydroxyl group on the polypeptide chain to form an ester bond. The acetate group is linked with the ester bond of Gonadorelin to form the structure of Gonadorelin acetate.
Three-dimensional configuration:
Stereoisomers exist in the polypeptide chain of Gonadorelin acetate. The side chains of different amino acids and the linkages between them can determine different three-dimensional configurations. Stereoconfiguration may have an effect on the activity and interaction of Gonadorelin acetate.
Hydrogen bonding and non-covalent interactions:
The amino acid residues on the Gonadorelin acetate polypeptide chain can interact through hydrogen bonds and other non-covalent interactions. These interactions can affect the stability, folding and biological activity of Gonadorelin acetate.
The above are some basic descriptions about the molecular structure characteristics of it. It is composed of polypeptide chains with a specific sequence of amino acids linked by acetate groups. Features such as stereoconfiguration, hydrogen bonding, and noncovalent interactions also play an important role in their properties. Note that these structural features are critical for understanding the pharmacological effects of Gonadorelin powder and interactions with other molecules.
Gonarelin can stimulate the synthesis and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) in the anterior pituitary gland, which can be used to detect pituitary gonadotropin reserve function. After injection of this product, the increase of LH in normal individuals is significantly higher than that of FSH, and the FSH response in prepubertal females is higher than LH. Individuals with insufficient gonadotropin-releasing hormone may experience delayed response after injection of the product, and sometimes require intravenous infusion of the product for several days before testing can begin.
Simulating the normal secretion rhythm of gonadotropin-releasing hormone in the hypothalamus, low-dose pulsed administration can be used to treat delayed puberty, amenorrhea, and infertility caused by hypothalamic etiology. If high-dose continuous administration is used, abnormal effects may occur after short-term stimulation of pituitary gonadotropins, instead inhibiting pituitary gonadal function. This phenomenon is more pronounced when using analogues with stronger and more lasting effects than the product itself.
Gonarelin is an artificially synthesized gonadotropin-releasing hormone, a peptide compound, and a decapeptide. This product can stimulate the synthesis and release of gonadotropins (FSH and LH) in the pituitary gland, while gonadotropins stimulate the release of sex hormones from the gonads. The secretion of gonadotropin-releasing hormone by the hypothalamus is regulated by multiple factors, including circulating sex hormones. Single dose use can increase circulating sex hormones; Continuous use can lead to downregulation of gonadotropin-releasing hormone receptors in the pituitary gland, thereby reducing the secretion of sex hormones.
Gonadorelin, Also known as gonadotropin-releasing hormone (GnRH), it is a decapeptide hormone secreted by the hypothalamus, whose main function is to regulate the release of gonadotropins (LH and FSH) from the anterior pituitary gland. The discovery of it can be traced back to the mid-20th century, when scientists began to have a strong interest in the regulatory mechanisms of the hypothalamic pituitary gonadal axis (HPG axis). In the 1960s, research teams led by American endocrinologists Roger Guillemin and Andrew Schally respectively isolated for the first time a substance from the hypothalamus of pigs and sheep that could stimulate the release of LH and FSH from the pituitary gland during the exploration of hypothalamic hormones.
After years of effort, Guillemin and Schally successfully isolated and identified the structure of it in 1971, determining it as a decapeptide hormone. This breakthrough discovery not only reveals the regulatory mechanism of the HPG axis, but also provides important experimental evidence for subsequent reproductive medicine research. In the 1970s and 1980s, with advances in peptide chemistry and molecular biology techniques, scientists gained a deeper understanding of the structure and function of it. In 1977, Guillemin and Schally were jointly awarded the Nobel Prize in Physiology or Medicine for their outstanding contributions in peptide hormone research. Afterwards, the research on Gonadorilin entered a new stage, and scientists began to explore its mechanism of action under different physiological and pathological conditions.
FAQ
Is the product legal?
+
-
It is available widely throughout the world for veterinary use, including in the United States, Canada, the United Kingdom, Ireland, elsewhere throughout Europe, South Africa, Australia, New Zealand, Japan, Taiwan. However, it is not available for clinical use in humans in the United States.
Does the product restore testicle size?
+
-
Patients on testosterone who wish to stem or reverse testicular shrinkage may use either gonadorelin or low-dose hCG. Gonadorelin may come with fewer estrogenic effects compared to hCG and is generally considered the drug of choice in younger patients with fertility aspirations.
Hot Tags: gonadorelin powder cas 34973-08-5, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, LONG R3 IGF I CAS 143045 27 6, Best Growth Hormone Releasing Peptide CAS 87616 84 0, Epitalon Powder CAS 307297 39 8, Melanotan 2 Powder, Tesamorelin CAS 218949 48 5, GLP 1 Peptide CAS 87805 34 3